CAS: 1402709-93-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CCT241736 REF: IN-DA01ENWXCAS: 1402709-93-6 | 99% | To inquire | Wed 08 Jan 25 |
 | CCT241736 REF: TM-T4428CAS: 1402709-93-6 | 96.2% - 99.88% | 59.00 €~482.00 € | Wed 15 Jan 25 |
 | CCT241736 REF: 3D-CGC70993CAS: 1402709-93-6 | Min. 95% | To inquire | Wed 19 Feb 25 |
CCT241736
CAS:1402709-93-6
Formula:
C22H23Cl2N7
Purity:
99%
Color and Shape:
Solid
Molecular weight:
456.3709
Ref: IN-DA01ENWX
| 1mg | 67.00 € | ||
| 5mg | 129.00 € | ||
| 10mg | 148.00 € | ||
| 25mg | 313.00 € | ||
| 50mg | 498.00 € | ||
| 100mg | To inquire | ||
| 200mg | To inquire |
Estimated delivery in United States, on Wednesday 8 Jan 2025
CCT241736
CAS:1402709-93-6
CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant …
Formula:
C22H23Cl2N7
Purity:
96.2% - 99.88%
Color and Shape:
Solid
Molecular weight:
456.37
Ref: TM-T4428
| 5mg | 59.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 167.00 € | ||
| 50mg | 323.00 € | ||
| 100mg | 482.00 € | ||
| 1mL*10mM (DMSO) | 67.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
CCT241736
CAS:1402709-93-6
CCT241736 is an effective dose of a clinical drug that belongs to the class of …
Formula:
C22H23Cl2N7
Purity:
Min. 95%
Molecular weight:
456.37 g/mol
Ref: 3D-CGC70993
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
